Botanical species · safety record

Oenanthe aquatica

The EFSA Compendium of Botanicals holds 5 constituent measurements for Oenanthe aquatica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Oenanthe aquatica (L.) Poir.

5Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Oenanthe phellandrium Lam.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Biochanin-a	Leaves	Solvent extraction	0.2 Milligram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Formononetin	Leaves	Solvent extraction	0.1 Milligram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Lignans	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Polyacetylene derivatives	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Polyacetylene derivatives	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Bohlmann, Ferdinand., Zdero, Christa., Trenel, Jochen., Haenel, Peter., Grenz, Michael. Polyacetylenic compounds. 194. Further polyynes from Umbelliferae. Chemische berichte, 1971, p. 1322-1328.
Chimichi, Stefano., Cosimelli, Barbara., Bambagiotti-Alberti, Massimo., Coran, Silvia A., Vincieri, Franco F. Complete 1H (600 MHz) and 13C NMR spectral assignments of 3,4-bis (3,4-dimethoxyphenyl)-methyl dihydro-(3R-trans)-2(3H)-furanone (matairesinol dimethyl ether), a naturally occurring dibenzylbutyrolactone lignan. Magnetic resonance in chemistry, 1993, p. 1044-1047.
Vincieri, Franco F., Coran, Silvia A., Giannellini, Valerio., Alberti, Massimo Bambagiotti. Oxygenated C15 polyacetylenes from Oenanthe aquatica fruits. Planta Medica, 1985, p. 107-110.
Abdulmanea, Khaled., Prokudina, Elena A., Lankova, Petra., Vanickova, Lucie., Koblovska, Radka., Zeleny, Vaclav., Lapcik, Oldrich. Immunochemical and HPLC identification of isoflavonoids in the Apiaceae family. Biochemical systematics and ecology, 2012, p. 237-243.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature